ArticleFrontiers in cell and developmental biology2025
Large language model-based multimodal system for detecting and grading ocular surface diseases from smartphone images.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Large Language Models for Ophthalmology Training in China: A Prospective Evaluation.Ophthalmology science · 2026Article
- Validated semi-supervised early and accurate screening for anterior segment diseases: a 3PM-guided conceptual and technological innovation.The EPMA journal · 2026Article
- Artificial Intelligence for Diagnostic Guidance in Ocular Surface Disorders.Journal of clinical medicine · 2026Review
- Benchmarking large language models for congenital cataract parent counseling: safety, readability, and knowledge translation of developmental and genetic information.Frontiers in cell and developmental biology · 2026Article
- Benchmark evaluation of multi-modal large language models for ophthalmic diagnosis in real world.Frontiers in medicine · 2026Article
- Patient education for neuromyelitis optica spectrum disorder using large language models: combining expert assessment and real-world patient interaction.Frontiers in physiology · 2026Article
- Comparative performance of GPT-4, GPT-o3, GPT-5, Gemini-3-Flash, and DeepSeek-R1 in ophthalmology question answering.Frontiers in cell and developmental biology · 2026Article
- ChatGPT-5 versus other mainstream large language models in core diabetic retinopathy patient queries.Frontiers in cell and developmental biology · 2026Article
- Artificial Intelligence Application in Cornea and External Diseases.Diagnostics (Basel, Switzerland) · 2025Review
- Clinical Applications of Artificial Intelligence in Corneal Diseases.Vision (Basel, Switzerland) · 2025Review
- Comparative performance of large language models for patient-initiated ophthalmology consultations.Frontiers in public health · 2025Article
- Multimodal reasoning agent for enhanced ophthalmic decision-making: a preliminary real-world clinical validation.Frontiers in cell and developmental biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The development of medical artificial intelligence (AI) models is primarily driven by the need to address healthcare resource scarcity, particularly in underserved regions. Proposing an affordable, accessible, interpretable, and automated AI system for non-clinical settings is crucial to expanding access to quality healthcare. Methods: This cross-sectional study developed the Multimodal Ocular Surface Assessment and Interpretation Copilot (MOSAIC) using three multimodal large language models: gpt-4-turbo, claude-3-opus, and gemini-1.5-pro-latest, for detecting three ocular surface diseases (OSDs) and grading keratitis and pterygium. A total of 375 smartphone-captured ocular surface images collected from 290 eyes were utilized to validate MOSAIC. The performance of MOSAIC was evaluated in both zero-shot and few-shot settings, with tasks including image quality control, OSD detection, analysis of the severity of keratitis, and pterygium grading. The interpretability of the system was also evaluated. Results: MOSAIC achieved 95.00% accuracy in image quality control, 86.96% in OSD detection, 88.33% in distinguishing mild from severe keratitis, and 66.67% in determining pterygium grades with five-shot settings. The performance significantly improved with the increasing learning shots (p < 0.01). The system attained high ROUGE-L F1 scores of 0.70-0.78, depicting its interpretable image comprehension capability. Conclusion: MOSAIC exhibited exceptional few-shot learning capabilities, achieving high accuracy in OSD management with minimal training examples. This system has significant potential for smartphone integration to enhance the accessibility and effectiveness of OSD detection and grading in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.